Correlation Between Sprint Bioscience and Devyser Diagnostics

Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Devyser Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Devyser Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sprint Bioscience AB and Devyser Diagnostics AB, you can compare the effects of market volatilities on Sprint Bioscience and Devyser Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Devyser Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Devyser Diagnostics.

Diversification Opportunities for Sprint Bioscience and Devyser Diagnostics

0.91

Correlation Coefficient

Sprint Bioscience  Devyser Diagnostics

Almost no diversification

The 3 months correlation between Sprint and Devyser is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Devyser Diagnostics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Devyser Diagnostics and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Devyser Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Devyser Diagnostics has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Devyser Diagnostics go up and down completely randomly.

Pair Corralation between Sprint Bioscience and Devyser Diagnostics

Assuming the 90 days trading horizon Sprint Bioscience AB is expected to generate 1.79 times more return on investment than Devyser Diagnostics. However, Sprint Bioscience is 1.79 times more volatile than Devyser Diagnostics AB. It trades about 0.17 of its potential returns per unit of risk. Devyser Diagnostics AB is currently generating about 0.22 per unit of risk. If you would invest  41.00  in Sprint Bioscience AB on May 21, 2025 and sell it today you would earn a total of  20.00  from holding Sprint Bioscience AB or generate 48.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Sprint Bioscience AB  vs.  Devyser Diagnostics AB

Sprint Bioscience

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sprint Bioscience AB are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Sprint Bioscience sustained solid returns over the last few months and may actually be approaching a breakup point.

Devyser Diagnostics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Devyser Diagnostics AB are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Devyser Diagnostics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sprint Bioscience and Devyser Diagnostics

The main advantage of trading using opposite Sprint Bioscience and Devyser Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Devyser Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Devyser Diagnostics will offset losses from the drop in Devyser Diagnostics' long position.

The idea behind Sprint Bioscience AB and Devyser Diagnostics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.